Revance Therapeutics Inc (NASDAQ:RVNC)

29.07
Delayed Data
As of 3:59pm ET
 -0.18 / -0.62%
Today’s Change
22.89
Today|||52-Week Range
34.62
+2.58%
Year-to-Date

Today’s Trading

Previous close29.25
Today’s open29.14
Day’s range28.82 - 29.55
Volume10,551
Average volume (3 months)402,257
Market cap$2.1B
Data as of 3:59pm ET, 07/30/2021

Growth & Valuation

Earnings growth (last year)-32.56%
Earnings growth (this year)+6.32%
Earnings growth (next 5 years)+192.00%
Revenue growth (last year)+3,610.65%
P/E ratioNM
Price/Sales107.27
Price/Book5.54

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...+0.12+0.87%
----
LGNDLigand Pharmaceutica...-5.56-4.66%
QTRXQuanterix Corp-0.58-1.08%
Data as of 3:59pm ET, 07/30/2021

Financials

Next reporting dateAugust 5, 2021
EPS forecast (this quarter)-$0.96
Annual revenue (last year)$15.3M
Annual profit (last year)-$282.1M
Net profit margin-1,840.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Nashville, Tennessee

Forecasts